← Open Payments lookup

OLIVIA DORMAN: Open Payments

NPI 1679336846 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$621 in 23 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $2,145 · 2025 $621

Food & beverage: $621
CompanyPaymentsAmount
Takeda Pharmaceuticals U.S.A., Inc.3$101
Regeneron Healthcare Solutions, Inc.3$85
Verona Pharma, Inc.3$67
GlaxoSmithKline, LLC.3$66
Amgen Inc.2$50
AstraZeneca Pharmaceuticals LP2$44
Becton, Dickinson and Company1$41
HARMONY BIOSCIENCES LLC1$40
Genentech USA, Inc.1$28
Vifor Pharma, Inc.1$27

Products named: DUPIXENT, GLASSIA, TEZSPIRE, Ohtuvayre, NUCALA, PleurX, WAKIX, Xolair.

Industry payments across MD — which companies pay providers there.